30 closest matches · ranked by relevance
HIV Infections
Primary: Blood Exposure — 1.9; 1.9 Number of Glove Pairs Used Per Razor Bla
Sars-CoV2 · Serum; Disease
Primary: Rate of Positive Serological Immune Status to a Previous Infection by the SARS-CoV-2 Virus at Inclusion — 18 Participants
Depressive Symptoms · Anxiety · Well-Being
Primary: Depressive Symptom Score Change — 5.29; 4.65 units on a scale
Resilience · Stress · Sleep
Primary: Perceived Stress Scale — -3.2 units on a scale
Alzheimer Disease · Dementia
Primary: Hospital Transfers — 1.2; 1.3 number of hospital transfers — p=0.3313
COVID-19
Primary: Change From Baseline in the Number of Participants With Seroconversion to SARS-CoV-2 at 1 Month — 4; 2 Participants
Healthy
Primary: PTSD Symptom Severity — 16.36; 17.10; 15.56; 15.78 score on a scale — p=.77
Vaccination
Primary: ELISA Seropositivity Rate — 40.9; 100.0 percentage of subjects
Brief Video-based Intervention · Non Intervention Control
Primary: Help-seeking Behavior — 8.2; 8.5; 9.3; 8.7 units on a scale
Bacterial Contamination of Healthcare Worker Uniforms
Primary: Total Bacterial Contamination of Healthcare Worker Uniform With Antimicrobial Properties Compared to Standard Healthcare Worker Uniform After an 8-hour Workday. — 41…
Pertussis
Primary: Evidence of Pertussis Infection in Each PEP Arm, Defined Using Clinical, Microbiologic, or Serologic Criteria. — 6; 1 participants
Hepatitis B · Hepatitis · Hepatitis, Viral, Human
Primary: Number of Participants With Protective Levels of Antibodies After Treatment — 63; 4 Participants
Influenza · Respiratory Syncytial Viruses · Paramyxoviridae Infections
Primary: Protective Effects of N95 Respirators vs Medical Masks (MM) as Assessed by Number of Influenza A and B Events — 222; 204 number of influenza A and B events
Increased Risk of SARS-CoV-2 Infection
Primary: Negative Polymerase Chain Reaction (PCR) — 2; 7 Participants
Hypertension · Arthritis · Coronary Artery Disease
Primary: Health Related Quality of Life (HRQOL) — 32.73; 32.74; 34.49; 33.89 score on a scale
COVID-19
Primary: Number of Participants With Clinical Infection With COVID-19 Infection — 41; 53 Participants — p=0.200
Alzheimer's Disease and Related Dementias
Primary: Change in Approaches to Dementia Questionnaire (ADQ) Total Score From Baseline to 3 Months — -1.8; -2.3 units on a scale
COVID-19 · SARS-CoV 2
Primary: Percent of Healthcare Workers Testing Positive for COVID-19. — 0; 0 percentage of healthcare workers
Healthcare Worker, Hepatitis B Vaccine, Nonresponder
Primary: Number of Participants Who Failed to Respond to 5 or More Doses of Hepatitis B Vaccine With Aluminum Adjuvant Who Respond to Hepatitis B Vaccine With CpG Adjuvant Series…
Influenza
Primary: Post-vaccination Geometric Mean Titer Against Influenza Virus A/H1N1 — 173.1; 83.9 titers
SARS-CoV2 Infection
Primary: Dental Health Care Worker (DHCW) Willingness to Participate in the Study — 10 Participants
Human Immunodeficiency Virus
Primary: Evidence of Toxicity. Toxicity Was Measured as Any Adverse Event; Nausea, Vomiting, Diarrhea. Elevated Liver Function Tests. — 4; 4 adverse events
Coronavirus · Coronavirus Infection · Coronavirus as the Cause of Diseases Classified Elsewhere
Primary: Number of New COVID 19 Infections — 25; 21 Participants
COVID-19
Primary: Number of Participants Infected With COVID-19 or COVID-19 Like Illness During the Trial — 13; 32 Participants — p=0.0112
Novel Influenza A/H1N1
Primary: Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation. — 234…
Influenza
Primary: Hemagglutination Inhibition (HI) Geometric Mean Titers (GMT) Post-vaccination (Day 28) of Each Vaccine Reference Virus — 584.2; 342.8; 217.4; 169.0 antibody titer…
Healthy
Primary: Number of Participants With Local and Systemic Adverse Events — 207 participants
SARS-CoV-2
Primary: Number of Participant Health Care Workers With a Positive Rapid, At-home, Point-of-care (POC) SARS-CoV2 IgG Antibody Test. — 8 Participants
Renal Anemia of Chronic Kidney Disease
Primary: Average Observed Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents (ESAs) — 38; 15; 17; 5 hours/year
Alzheimer's Disease and Related Dementias
Primary: Neuropsychiatric Inventory Questionnaire Average Score During Hospital Admission — 5.36; 3.87 score on a scale